MIRAVANT MEDICAL TECHNOLOGIES
S-8, EX-5, 2000-08-29
PHARMACEUTICAL PREPARATIONS
Previous: MIRAVANT MEDICAL TECHNOLOGIES, S-8, 2000-08-29
Next: MIRAVANT MEDICAL TECHNOLOGIES, S-8, EX-23, 2000-08-29





                                   EXHIBIT 5.1

                   OPINION OF WILSON SONSINI GOODRICH & ROSATI


                                 August 25, 2000

Miravant Medical Technologies
336 Bollay Drive
Santa Barbara, CA  93117

        Re:   Miravant Medical Technologies - Registration Statement on Form S-8
              ------------------------------------------------------------------

Ladies and Gentlemen:


         We have examined the Registration  Statement on Form S-8 to be filed by
you with the Securities and Exchange Commission on or about August 29, 2000 (the
"Registration   Statement")  in  connection  with  the  registration  under  the
Securities  Act of 1933,  as amended,  of 6,000,000  shares of your Common Stock
reserved  for  issuance  under the  Miravant  Medical  Technologies  2000  Stock
Compensation  Plan (the  "Plan").  As your legal  counsel,  we have examined the
proceedings taken and are familiar with the proceedings taken and proposed to be
taken by you in connection with the sale and issuance of such Common Stock under
the Plan.

         It is our opinion that,  when issued and sold in the manner referred to
in the Plan and pursuant to the agreements  which accompany the Plan, the Common
Stock issued and sold thereby will be legally and validly issued, fully paid and
non-assessable.

         We consent to the use of this opinion as an exhibit to the Registration
Statement and further  consent to the use of our name wherever  appearing in the
Registration  Statement,  including any Prospectus  constituting a part thereof,
and any amendments thereto.

                                   Sincerely,

                                   /s/ Wilson Sonsini Goodrich & Rosati
                                   ------------------------------------
                                    WILSON SONSINI GOODRICH & ROSATI
                                    Professional Corporation



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission